4D Molecular Therapeutics Inc

NASDAQ:FDMT  
22.88
-0.38 (-1.63%)
2:40:32 PM EDT: $22.19 -0.69 (-3.02%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)729.06M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3 Million
Adjusted EPS-$0.80
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

4D Molecular Therapeutics Inc Stock, NASDAQ:FDMT

5858 Horton Street, Suite 455, Emeryville, California 94608
United States of America
Phone: +1.510.505.2680
Number of Employees: 124

Description

4D Molecular Therapeutics, Inc. engages in the design, development, and commercialization of transformative gene therapeutic products for serious unmet medical conditions. It offers products for ophthalmology, cardiology, and pulmonology. The company was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer on September 12, 2013 and is headquartered in Emeryville, CA.